Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BIO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Rad Laboratories (BIO) trades at $316.41, up 0.62% on the day, with a bullish technical signal from moving averages but overbought RSI levels. The company reported revenue of $2.58B in 2025 with a net income margin of 29.41%, though recent quarterly EPS misses have occurred. Analyst consensus is a Buy with a $305 price target, and activist involvement highlights value-unlocking potential, as noted by Seeking Alpha on July 2, 2026.
Outlook is cautiously optimistic given strong profitability and cash flow, but risks include earnings volatility and high valuation multiples. The stock's proximity to its 52-week high suggests limited near-term upside, while institutional buying and a debt-to-asset ratio of 11.38% support stability. Investors should monitor the Q2 2026 earnings report on August 4 for confirmation of growth trends.
Read full analysis

Key Stats

  • Market Cap
    $8.39B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $339.75
  • 52W Low
    $241.71
  • Typical Hold Time
    -
  • Enterprise Value
    $8.20B
  • Div Yield
    -
  • Trading Activity
    -
$316.8
52W Low: $241.71
12 May 2026
52W High: $339.75
24 Oct 2025

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $339.75, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Most Recent News

Content is generated by Aura AI

Johnson & Johnson agrees to $5.5B settlement over talc products linked to cancer claims.

Johnson & Johnson has reached a historic $5.5 billion settlement to resolve claims from about 70,000 women and families alleging its talc products, including Johnson's Baby Powder, contained asbestos and caused cancers such as ovarian cancer and meso...

Market News
43 minutes ago
Levin Papantonio
Bearish
news icon
pluang ai news

Blue Gold receives Nasdaq notice for not meeting $15M minimum market value of public shares.

Blue Gold Limited was notified by Nasdaq that it does not meet the minimum Market Value of Publicly Held Shares (MVPHS) requirement of $15 million, based on market values from June 10 to July 23, 2026. The company has 180 days, until January 20, 2027...

Market News
4 hours ago
Na
Bearish
news icon
pluang ai news

GOP urged to improve messaging on economic gains and America First values ahead of midterms.

Larry Kudlow highlights that recent tax cuts have notably benefited lower and middle-income workers with wage increases, while prescription drug prices have dropped. Despite these gains, many voters remain unaware of the bill's benefits, posing a cha...

Market News
4 hours ago
Fox Business
Neutral
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $8.39B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $339.75
  • 52W Low
    $241.71
  • Typical Hold Time
    -
  • Enterprise Value
    $8.20B
  • Div Yield
    -
  • Trading Activity
    -
$316.8
52W Low: $241.71
12 May 2026
52W High: $339.75
24 Oct 2025

Track Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $241.71 and a high of $339.75, highlighting its annual price range. Buy and sell Bio-Rad Laboratories, Inc. Class A Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!